{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-30T12:33:26.123273+00:00",
  "news": [
    {
      "title": "Sagebrush Lawsuit Tests Amgen 340B Practices And Investor Risk Views - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQTjJwMmdQLU10ZW53Mjdkek1sUUxsNEdpZjl3UlhZRUR2Vm5vX3BiOVNKY3dFRVhwX2ZWQzhLYXBkZU9FQTg2d2docl9BdWx0Q0pSVlJRTVRpM09hTFB4N09ocUUwYUplVlU1blhXX1ZtTGRnVm1iWlZDM0ZRNjhEWjFaZHhiY1NyLWppZ2dLM190Q3JMTmhBMW5nTERnQ2FGMHFOaWJpN0tvSVowMWQxcWUydHphWnRFWFZQSW5nTkNuNzNqazB6SXJDd3pFSDhuOGxBODBR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQTjJwMmdQLU10ZW53Mjdkek1sUUxsNEdpZjl3UlhZRUR2Vm5vX3BiOVNKY3dFRVhwX2ZWQzhLYXBkZU9FQTg2d2docl9BdWx0Q0pSVlJRTVRpM09hTFB4N09ocUUwYUplVlU1blhXX1ZtTGRnVm1iWlZDM0ZRNjhEWjFaZHhiY1NyLWppZ2dLM190Q3JMTmhBMW5nTERnQ2FGMHFOaWJpN0tvSVowMWQxcWUydHphWnRFWFZQSW5nTkNuNzNqazB6SXJDd3pFSDhuOGxBODBR?oc=5\" target=\"_blank\">Sagebrush Lawsuit Tests Amgen 340B Practices And Investor Risk Views</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-01-30T07:40:32+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "UBS Raises Amgen (AMGN) Target as Pharma and Biotech Setup Improves - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5aT04yclFCbmtmazd6NzR3UXhPcklOZ1dkQkF0ZlNGWmMyb2VoRG9CQ0NIS3VoeWpwdkVmako5aDVkcDdSSzJ6eUd3cWY1QWJoNGMtUTFyelJSbFNYUXpZbk5ZbkNsX1FkdmUtb1J4N3k1TFBkTVhLNE1IZThEeDA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMif0FVX3lxTE5aT04yclFCbmtmazd6NzR3UXhPcklOZ1dkQkF0ZlNGWmMyb2VoRG9CQ0NIS3VoeWpwdkVmako5aDVkcDdSSzJ6eUd3cWY1QWJoNGMtUTFyelJSbFNYUXpZbk5ZbkNsX1FkdmUtb1J4N3k1TFBkTVhLNE1IZThEeDA?oc=5\" target=\"_blank\">UBS Raises Amgen (AMGN) Target as Pharma and Biotech Setup Improves</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-29T17:24:16+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "AMGEN ANNOUNCES WEBCAST OF 2025 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS - lompocrecord.com",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">AMGEN ANNOUNCES WEBCAST OF 2025 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">lompocrecord.com</font>",
      "published": "2026-01-28T21:01:00+00:00",
      "source": "lompocrecord.com"
    },
    {
      "title": "AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5\" target=\"_blank\">AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2026-01-06T08:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Ro partners with Amgen to study barriers to obesity care, GLP-1 access - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5\" target=\"_blank\">Ro partners with Amgen to study barriers to obesity care, GLP-1 access</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2026-01-13T08:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Amgen R&D EVP James Bradner On Upcoming Readouts And Doing Deals Around New Capabilities - Citeline News & Insights",
      "link": "https://news.google.com/rss/articles/CBMigwJBVV95cUxNWURzdlRxdXRsZDRXdS1xeUZuTXNwdThIdXVGM2RZcnlORFJoSnBCWG5zdmR2M2dUbm41d1VUdFREbDl6WndWM0xtQWFfZjVHcXlUUlVJMzI2SUU1aGI1STlzNUEtZnJZUkJzZG04WjQ2Z3JPN0plUnM2a1BJelhZREViWl92andPdGhoOWpGMWxsTGZ5Z0txVG1EU3lXUEdCZTBibWRWcUROZTBqVDJlOXc4Z1BTaU96MnZrdXRKanZVRnZQR3lBd3I3SS1ucTNIM1BPOUt2RTFEY05Ia3VrU0JlQmVlZktlTGk1MHlaZGpRbURWRGZQdkcwQXFIeVdIZktZ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwJBVV95cUxNWURzdlRxdXRsZDRXdS1xeUZuTXNwdThIdXVGM2RZcnlORFJoSnBCWG5zdmR2M2dUbm41d1VUdFREbDl6WndWM0xtQWFfZjVHcXlUUlVJMzI2SUU1aGI1STlzNUEtZnJZUkJzZG04WjQ2Z3JPN0plUnM2a1BJelhZREViWl92andPdGhoOWpGMWxsTGZ5Z0txVG1EU3lXUEdCZTBibWRWcUROZTBqVDJlOXc4Z1BTaU96MnZrdXRKanZVRnZQR3lBd3I3SS1ucTNIM1BPOUt2RTFEY05Ia3VrU0JlQmVlZktlTGk1MHlaZGpRbURWRGZQdkcwQXFIeVdIZktZ?oc=5\" target=\"_blank\">Amgen R&amp;D EVP James Bradner On Upcoming Readouts And Doing Deals Around New Capabilities</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Citeline News & Insights</font>",
      "published": "2026-01-27T18:58:37+00:00",
      "source": "Citeline News & Insights"
    },
    {
      "title": "The Escalator: Regeneron, Lundbeck, Amgen and more - Medical Marketing and Media",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNX29qdTFEZk5FNXUzcG90emRQb1lMTmxyMUNLQTNMWUZrQXgwcXE4aGFfdy0xekFVNXhlSHEwaTQwZWxQbWFxV0g1dzE4V1liLVZTRkI5bUFWblZwa2ctQVlvM3BNTEVoeVVwWUxwdWxxTHQyOWM1d1o2R0JNbWRLb0QzUnJiUlU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxNX29qdTFEZk5FNXUzcG90emRQb1lMTmxyMUNLQTNMWUZrQXgwcXE4aGFfdy0xekFVNXhlSHEwaTQwZWxQbWFxV0g1dzE4V1liLVZTRkI5bUFWblZwa2ctQVlvM3BNTEVoeVVwWUxwdWxxTHQyOWM1d1o2R0JNbWRLb0QzUnJiUlU?oc=5\" target=\"_blank\">The Escalator: Regeneron, Lundbeck, Amgen and more</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Medical Marketing and Media</font>",
      "published": "2026-01-29T12:00:59+00:00",
      "source": "Medical Marketing and Media"
    },
    {
      "title": "Amgen CEO says weight loss drug can address 'patient persistence issue' - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5\" target=\"_blank\">Amgen CEO says weight loss drug can address 'patient persistence issue'</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2026-01-13T08:00:00+00:00",
      "source": "CNBC"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    },
    {
      "title": "Amgen History - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE53MklERTNSbkNVaXhYQ3dPcEtDRU1uTW5mLUdxSGFtZ0wxMmFZSlQ1SnZkY1hZOFZ1RmRsZjNXMGYtM1hQXzl0R0NJSmtQLVJnYzlN?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE53MklERTNSbkNVaXhYQ3dPcEtDRU1uTW5mLUdxSGFtZ0wxMmFZSlQ1SnZkY1hZOFZ1RmRsZjNXMGYtM1hQXzl0R0NJSmtQLVJnYzlN?oc=5\" target=\"_blank\">Amgen History</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2020-12-12T03:24:17+00:00",
      "source": "Amgen"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-29",
      "close": 342.94000244140625
    },
    "history": [
      {
        "date": "2026-01-21",
        "close": 343.6000061035156
      },
      {
        "date": "2026-01-22",
        "close": 347.07000732421875
      },
      {
        "date": "2026-01-23",
        "close": 344.75
      },
      {
        "date": "2026-01-26",
        "close": 349.69000244140625
      },
      {
        "date": "2026-01-27",
        "close": 351.32000732421875
      },
      {
        "date": "2026-01-28",
        "close": 342.2200012207031
      },
      {
        "date": "2026-01-29",
        "close": 342.94000244140625
      }
    ],
    "name": "Amgen Inc."
  }
}